The efficacy of low dose short-term prednisone therapy for remission induction in newly diagnosed rheumatoid arthritis patients
Abstract Background The ACR/EULAR recommendations endorse the use of glucocorticoids (GCs) for rheumatoid arthritis (RA) patients’ flares and as a bridge to a DMARD. However, the recommendation of low dose short-term monotherapy with (GCs) remains open to the discretion of the clinician. The aim of...
Main Authors: | John M. Stacy, Jacob R. Greenmyer, James R. Beal, Abe E. Sahmoun, Erdal Diri |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-08-01
|
Series: | Advances in Rheumatology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s42358-021-00205-4 |
Similar Items
-
Patterns of Prednisone Use in Patients with Rheumatoid Arthritis Initiating Treatment with Tocilizumab in Routine US Clinical Practice
by: Dimitrios A. Pappas, et al.
Published: (2019-06-01) -
Rheumatoid Arthritis: Defining Clinical and Ultrasound Deep Remission
by: Corominas Hèctor, et al.
Published: (2020-01-01) -
RHEUMATOID ARTHRITIS: THE PROBLEMS OF REMISSION AND THERAPY RESISTANCE
by: E. L. Nasonov, et al.
Published: (2018-07-01) -
Efficacy and safety of modified-release prednisone in patients with rheumatoid arthritis
by: Krasselt M, et al.
Published: (2016-03-01) -
Ultrasonographic findings of rheumatoid arthritis patients who are in clinical remission
by: Hadi Karimzadeh, et al.
Published: (2018-01-01)